FEELM
19.5.2022 10:43:11 CEST | Business Wire | Press release
FEELM, the flagship atomization tech brand belonging to SMOORE, today released its “Race to Zero” plan and roadmap to carbon neutrality. The plan brings forward FEELM’s ambitions to achieve net-zero carbon emissions by 2050 in its direct production activities and indirect purchased energy (scope 1&2). Meanwhile, FEELM makes a commitment that renewable energies will account for 30% of its total energy consumption by 2030.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220519005482/en/
As one of China’s first atomization tech brands to make a carbon neutrality commitment, FEELM pledges to reach net zero in full supply chain and full product lifespan by developing sustainable products, improving energy efficiency with automated production, supporting the supply chain in decarbonization, and increasing renewable energies and eco-friendly materials.
FEELM, being the world ‘s largest closed vape system solution provider, plays a significant role in the global vaping supply chain. On the one hand, it provides millions of global consumers with premium product experience by virtue of partnership with vaping brands around the world; on the other hand, FEELM has been leading a sustainable revolution in the supply chain.
Leading on Sustainability by introducing FUTURE series solutions
FEELM has been leading on sustainability and green product innovations, which is the industry’s driving force towards carbon neutrality. Committed to providing global customers with zero carbon technologies, FEELM has introduced FUTURE series solutions, which feature recyclability, disassemblability, biodegradability and minimalist design.
Since 2019, FEELM has already pioneered a number of green vaping solutions. For example, it won iF Design Award 2020 for disposable paper e-cigarette, which is made up of spiral composite paper tube, improving the degradability rate to approximately 76% of the total volume, compared with the plastic used in traditional vaping products.
Moreover, FEELM is ready to unveil another eco-friendly non-nicotine disposable e-cigarette at Vaper Expo UK 2022 in late May . This product was awarded Red Dot Awards for Product Design 2022. Its external structure is composed of recyclable and reusable aluminum foil. It looks like a paper foil pouch and itself serves as a packaging bag, hence the reduction of packaging materials.
Supporting the Global Supply Chain in Decarbonization
In addition to developing sustainable products, FEELM has also partnered with suppliers to develop and encourage utilizing biodegradable materials while optimizing the water, electricity and gas consumption management. FEELM is also working with global customers to promote the recycling and reusing, so as to explore a feasible path towards carbon neutrality for the product lifespan and the supply chain.
As a manufacturer with environmental awareness, FEELM has supported vaping brands around the world in reducing carbon footprint and empowered our customers to achieve carbon neutrality in 2050, by eliminating unnecessary plastic packaging. For example, FEELM removed single-use plastics from packaging of one of its major customers. Having removed silicone caps from e-liquid pods, it replaced all plastic tray packaging with a pulp alternate. By 2020, FEELM had already helped this customer save over 100 tons of disposable plastics, which are equivalent to 4 million plastic bottles.
To date, China has accounted for close to 90% of global production of vaping products. As the world ‘s largest closed vape system solution provider, FEELM is devoted to facilitating carbon neutrality of the whole supply chain. It has been exploring innovative, customized carbon reduction solutions along with partners, covering a full circle from raw material supply, product design, production, consumption to recycling and reusing.
FEELM has established a series of automated production lines to optimize energy efficiency. According to its in-house greenhouse gas control and water management procedures, FEELM’s greenhouse gas emissions and water consumption have decreased by 16% and 9.4% year-on-year in 2021 respectively. For example, one of FEELM’s automatic factory has saved 2.298 million kilowatts of electricity, which is equivalent to a reduction of 601 tons of carbon emissions in 2021.
Complying with International Standards, and Making Carbon Management More Transparent
Aiming for the goal that 30% of total energy consumption will come from renewable source by 2030, FEELM is also benchmarked against the standards of international organizations. In 2022, FEELM has introduced Carbon Disclosure Project (CDP) standards to its operation and production. Moving forward, FEELM plans to set up science-based emission reduction targets by submitting to Science Based Targets initiative (SBTi).
The Science Based Targets initiative (SBTi) is a collaboration established in 2015 between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). By May 11, 2022, there are 2,466 companies from more than 70 countries and regions have joined the initiative, including 152 Chinese companies and one fifth of Forbes 500 companies.
“As a pioneer in going global in Chinese vaping industry, FEELM has been leveraging its full supply chain advantages and fundamental R&D in reducing carbon footprints. As China has pledged to be carbon neutral by 2060, FEELM is ready to fulfill its carbon neutral commitment to Chinese vaping industry, so as to explore a lower-carbon, greener and more sustainable development path with cutting-edge technologies,” said Frank Han, Senior Vice President of SMOORE and President of FEELM.
Moving forward, FEELM will continue to reduce the carbon footprints of vaping products by promoting the R&D and application of innovative green technologies and eco-friendly materials. In collaboration with suppliers and clients, FEELM is also committed to exploring and developing the recycling and reusing mechanism of vape pod cartridges, thereby playing a more significant role in the decarbonization of the industry.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220519005482/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
